Universitat: Salamanca

Grup d'investigació: NEUROBIOQUÍMICA

Correu: andrea.av@usal.es

Doctora per la Universidad de Salamanca amb la tesi Translational steps towards the clinical application of tat-cx43266-283 for the treatment of glioblastoma egfr as a predictor and mediator of treatment response, and positive results in combination with tumor resection in a preclinical model 2024. Dirigida per Dra. María Aránzazu Tabernero Urbieta.